Impact BioMedical, Inc.
IBOImpact BioMedical, Inc. is a biotechnology company that develops and manufactures medical devices and products primarily for wound care, surgical, and regenerative applications. The company focuses on innovative solutions to improve patient outcomes, including advanced wound dressings and dermal fillers.
Company News
ImPact Biotech announced updated clinical trial data for Padeliporfin VTP, a vascular-targeted photodynamic therapy. In the Phase 1 LA-PDAC trial, 71% of patients (5/7) achieved successful surgical resection with a well-tolerated safety profile. The Phase 3 ENLIGHTED trial in LG-UTUC showed 70% complete response rates with 85.7% of patients susta...
ImPact Biotech announced updated Phase 3 ENLIGHTED trial results for Padeliporfin VTP in low-grade upper tract urothelial cancer, showing 70% complete response rate in 72 evaluable patients and 85.7% durability at 12 months. The treatment demonstrated a consistent safety profile with mostly mild to moderate adverse events. Topline data expected l...
Impact BioMedical Inc. (NYSE American: IBO) received a 'going concern' qualification in its 2025 10-K audit opinion from Grassi & Co., CPAs, indicating substantial doubt about the company's ability to continue operations. Despite this financial concern, the company continues pursuing a strategic merger with Dr. Ashley's Ltd., projected to close b...
Impact Biomedical (IBO) shares surged 86.28% in after-hours trading to $0.77 following an SEC filing that disclosed amendments to its pending merger with Dr Ashleys Bio Labs Limited. The merger agreement was extended from March 31 to July 1, 2026, with revised share allocations. Dr Ashleys will issue 169.5 million shares (94.20% of total), while ...
DSS, Inc. announced that its subsidiary, Impact BioMedical Inc., has entered into a definitive merger agreement with Dr. Ashleys Limited, a global pharmaceutical company. The transaction will result in a newly formed combined entity traded on the NYSE American under the name 'Dr Ashleys Limited'.
